Companies: 10,795·Total market cap: $144.5T
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCONYSEHealthcare● Active
$15.15
$-0.32(-2.04%)
Market Cap$5.4B
P/E Ratio
52W High$18.915
52W Low$11.44

Bausch + Lomb Corporation(BLCO)股东结构

基于 13F 申报与流通股数据,展示机构、内部人与公众持股结构;下方为前十大机构、机构动向与内部人交易。

SEC 13F · FMP · BLCO · 截至 2025年9月30日

股东结构概览

机构 10.89%
内部人 87.4%
散户 1.71%

102

机构持有人数

▼ 2 vs Q2

$586.31M

机构持仓总市值

▲ $90.20M vs Q2

356.54M

总流通股

freeFloat 12.60%

38.83M

13F 申报持股数

▲ 750,090 vs Q2

机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源:FMP /symbol-positions-summary + /shares-float + SEC EDGAR。

前10大机构持仓

BLCO 最大股东 · 机构持仓

Q3 2025 · SEC 13F

显示前 10 家

机构持股数占比权重市值申报日变动

ICAHN CARL C

ophthalmic goods

3.50M98.95%

98.95%

$52.74BNov 14, 2025— held

DEUTSCHE BANK AG\

ophthalmic goods

3.50M98.95%

98.95%

$52.74BNov 13, 2025 89.9K

OAKTREE CAPITAL MANAGEMENT LP

ophthalmic goods

3.25M91.76%

91.76%

$48.91BNov 13, 2025 724.2K

GOLDENTREE ASSET MANAGEMENT LP

ophthalmic goods

2.66M75.22%

75.22%

$40.00BNov 14, 2025 77.3K

D. E. SHAW & CO., INC.

ophthalmic goods

2.61M73.71%

73.71%

$39.29BNov 14, 2025— held

SILVER POINT CAPITAL L.P.

ophthalmic goods

2.56M72.52%

72.52%

$38.65BNov 14, 2025NEW

FMR LLC

ophthalmic goods

1.56M44.11%

44.11%

$23.51BNov 13, 2025 788.3K

GLENVIEW CAPITAL MANAGEMENT, LLC

ophthalmic goods

1.55M43.93%

43.93%

$23.42BNov 14, 2025— held

NOMURA HOLDINGS INC

ophthalmic goods

1.26M35.52%

35.52%

$18.93BNov 14, 2025— held

PRICE T ROWE ASSOCIATES INC /MD/

ophthalmic goods

1.24M34.97%

34.97%

$18.64BNov 14, 2025 12.3K

数据来源:SEC 13F 申报文件。变动标识:isNew / isSoldOut / changeInSharesNumber。

机构仓位变动

Q3 2025 对比上季度

Q3 2025

机构整体情绪偏多 — 增持多于减持

21

增持

+5.08M 股

5

新建仓

首次建仓

14

减持

−1.85M 股

0

清仓

完全退出

净股数变化(前50家)

+3.22M

+5.08M / −1.85M

净新增持仓人

+12

新建 5 个 / 退出 0 个

基于前50家最大机构持仓统计,全市场实际数量可能不同。

内幕交易买卖情绪

BLCO 内幕交易记录

数据来源:SEC Form 4

13

买入笔数

7

卖出笔数

1.86

买卖比

$0M

卖出总金额

最近内幕交易记录

最近10条 · 仅普通股

姓名 · 职位日期类型股数价格金额交易后持股申报

VON ESCHENBACH ANDREW C.

director

May 26, 2026Award15,842$15.78$250.0K86.7KForm 4 ↗

Ross Thomas W. Sr.

director

May 26, 2026Award15,842$15.78$250.0K85.2KForm 4 ↗

ROBERTSON RUSSEL C

director

May 26, 2026Award15,842$15.78$250.0K94.3KForm 4 ↗

Paulson John

director

May 26, 2026Award15,842$15.78$250.0K89.8KForm 4 ↗

Ling Karen

director

May 26, 2026Award15,842$15.78$250.0K61.5KForm 4 ↗

KAVANAGH SARAH B

director

May 26, 2026Award15,842$15.78$250.0K69.5KForm 4 ↗

COLLIS STEVEN H

director

May 26, 2026Award15,842$15.78$250.0K42.0KForm 4 ↗

Bernier Nathalie D.

director

May 26, 2026Award15,842$15.78$250.0K85.5KForm 4 ↗

Alfonso Eduardo

director

May 26, 2026Award15,842$15.78$250.0K31.1KForm 4 ↗

SAUNDERS BRENT L

Chairman of the Board and CEO

May 22, 2026Tax Withhold2,886$15.92$45.9K978.4KForm 4 ↗

数据来源:SEC Form 4。买卖方向:acquisitionOrDisposition A=买入,D=卖出。已排除 RSU 归属(M-Exempt)。

关于机构与内部人持股结构

Bausch + Lomb Corporation(BLCO)主要由机构投资者持有,机构持股比例约为 10.9%。公司内部人员持股约 87.40%,散户及公众持股约占剩余的 1.71%。

Bausch + Lomb Corporation 最大机构股东为 ICAHN CARL C,截至 September 30, 2025 持有约 3.50 million 股,占总流通股的 98.95%。

目前共有 102 家机构持有 BLCO 股票,合计持仓市值约 $586,310,241,数据来源为最新 SEC 13F 申报。

常见问题

BLCO ownership

Bausch + Lomb Corporation(BLCO)主要由机构投资者持有,机构持股约 10.9%。最大股东为 ICAHN CARL C,持股比例 98.95%。内部人员持股约 87.40%。数据来源 SEC Form 13F,截至 September 30, 2025。

who owns BLCO stockBLCO ownership structureSEC Form 13F institutional holdingsBLCO float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025